GEN Exclusives

More »

Wall Street BioBeat

More »
Apr 1, 2010 (Vol. 30, No. 7)

IP Position Critical to Biotech Investment

Looming Battle over Gene Patenting Could Jeopardize Medical Advances

  • Takeaways: The Case for Gene Patents

    • Gene patents are the foundation of the biotech industry and precluding them would halt forward progress.
    • The patent system promotes innovation and stimulates investment in R&D.
    • If there were no exclusive rights in the final product, there would be
      little incentive to invest time and money into developing it.
    • Without the incentives offered by the issuance of patents, the industry and, ultimately, patients would suffer.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?